In addition, accumulating evidence shows that GBM features hyperactive AKT signaling and that clinical use of TMZ can stimulate endogenous AKT kinase activity5, which is involved in various cellular processes, including cell survival, growth, metabolism, and proliferation6. Here, AKT1 is linked to glioblastoma.